Introduction
U'e have presented evidence recently that subinhibitory concentrations of trimethoprim and sulphonamides mutually enhance their uptake by bacteria. even when the bacteria iirc resistant to one member of the combination. ' ' Thus a strain of E~ritvdxii*tt-'r clowcit) for which the MIC of sulphadiai.inc was > 3000 pg/mI. and that of trimethoprim wiis 15 ,ug/ml, was inhibited by a combination of sulphadiazinc 100 pg/Inl and trirnethoprim 7-5 pg/ml. The s) nergy correlated with markedly increased uptahc of' the two compounds. This provided an expl a n a t i o n fo r a n t i bacteria 1 synergy be t w ee n s u 1 p h o namides and trimethoprim alternative to the sequential blockade of folate synthesis. Similar increases in the combined uptake of sulphadiazine and trimethoprim were obtained with two strains of Psc~irdor~ioi~cis cimryiiiosci that were resistant to high concentrations of both antibacterial agents used alone.'
'The pur-post. o f the present investigation was to in\,cstigatt" the morphological effects of sulphadiazine 3nd trimerhoprirn on log phase cells of E. c h m i e . to clarif! furthcr o u r earlier findings.' :' An additional objcctit e was t o dctermine whether the sulphadiazine could contribute to the bactericidal action of the coinbination against a strain that was highly resistant to thc sulphonamicie. It is well known that sulphonantides contribute I O the bacteriostatic action of sulphonamide-trimethoprim combinations against sensitive bacteria, but there is considerable uncertainty as to whether they contribute to bactericidal synergy, especialfy if the bacteria are sulphonamide resistant."'
Materials and methods
E. c~louc.~icl NCTC 10005 was obtained from the National Collection of Type Cultures, Colindale Avenue, London. Sulphadiazine, trimethoprim and y-aminobenzoic acid were from Sigma.
Simple pwparutioii
From an 18-h broth culture of E. caloac.ur 1 ml was inoculated into 99 ml of Iso-Sensitest Broth (Oxoid) at 37°C in a 250-ml conical flask. The culture was shaken at 100 oscillations/min in a water bath at 37°C for 4 h ; 10-mi quantities of this log phase culture were then inoculated into 250-ml conical flasks containing 90 ml of Iso-Sensitest broth plus sulphadiazine 250 pg/ml, or trimethoprim 12.5 pg/ml, or both. A flask containing 90 ml of Iso-Sensitest broth without an antibacterial agent was used as the control. These four flasks were incubated at 37°C for 4 h in a water bath with shaking ( 100 oscillations/min).
The cultures were centrifuged at 6000 y for 15 min at 4°C. and the supernate was removed. The pellet was fixed in glutaraldehyde 8 % v/v in 0-1 M phosphate buffer (pH 7.2) for 1 h, and then in glutaraldehyde 4 % v/v in 0.1 M phosphate buffer (pH 7-2) for 4 h at 4°C. After washing in the same buffer the bacteria were resuspended in OsO, (Emscope, Watford) 1 % w/v for 1 h at room temperature. They were then washed three times by centrifugation and resuspension in distilled water. The final pellet was resuspended in a small volume of warm agarose 2 O h w/v, poured on to a glass slide and allowed to cool. When set, small pieces of gel containing suspended bacteria were cut out and dehydrated through a graded series of ethanol solutions. After embedding in Araldite (Agar Scientific Ltd, Stansted, Essex) thin sections were cut with a diamond knife on a Reichert Ultracut E ultramicrotome, stained with uranyl acetate and lead citrate, and examined in a Philips EM301 electronmicroscope operating at 80 kV.
Treatment with disodium edetate plus lysozjlme
From a log phase culture of E. cloacae, 10-mi volumes were inoculated separately into three 250-ml conical flasks each containing 90 ml of IsoSensitest were then centrifuged and the cell pellets were washed with HEPES buffer (pH7.2) and resuspended in the same colume of buffer solution. Lysozyme was added to give a concentration of 50pg/ml followed by disodium edetate to a concentration of 0.1 mM. The action of disodiuni edetate was quenched after 45, 60 and 90 5 . respectiiely. by the addition of sufficient Mg('1: to achieve ii concentration of 40 mM. After the lysoryme had reacted with the cells for 4 min at 2OoC, the suspensions were centrifuged and prepared for electronmicroscopy as described above.
Viable counts were determined by an overdried agar plate counting method. From a log phase culture 10-ml volumes were added to three flasks containing 90 ml of Iso-Sensitest broth with and without the appropriate antibacterial agent. Viable counts were determined after exposure to the antibacterial agents for 30 min, 1 h, 2 h, 3 h, 4 h and 5 h. p-Aminobenzoic acid 50 pg/ml was incorporated into the Iso-Sensitest agar to antagonise any sulphadiazine or trimethoprim which could have been present in low concentrations in the cells, since p-aminobenzoic acid at appropriate concentrations not only blocks the antibacterial activity of sulphadiazine but also that of trimethoprim (unpublished results). Fig. 1 shows the appearance of normal log phase cells of E. cloacae NCTC 10005.
Results

Electronmicroscopy
After exposure to sulphadiazine 250 pg/ml, at least 50 O/ O of the bacteria exhibited electron-transparent areas devoid of ribosomes (holes) clearly visible within the cytoplasm (fig. lc) . Also, the gap between the cytoplasmic and outer membranes appeared larger and less electron-dense ( fig. Id) .
Approximately two-thirds of bacteria exposed to trimethoprim 12.5 pg/ml had holes similar to those seen in the sulphadiazine-treated bacteria ( fig. 2a ). In addition, there was partial detachment of the outer membrane from the cytoplasmic membrane in most of the bacteria. The membrane generally appeared to be unbroken although detached ; however, where the holes were adjacent to the cytoplasmic membrane the membrane often appeared to be broken. Higher magnification showed that only certain areas of the cytoplasmic membrane remained connected to the outer membrane ( fig. 2b) .
When E. cloacae NCTC 10005 was exposed to the combination of sulphadiazine 250 ,ug/ml and trimethoprim 12.5 ,ug/ml all the bacteria exhibited damage ( fig. 2c and d) . Fig. 3 shows that brief exposure to disodium edetate plus lysozyme had an effect on the morphology of the E. cloacae NCTC 10005 strikingly similar to that of the antimetabolites.
Viable counts
Sulphadiazine 250 ,ug/ml slowed the replication of the inoculum of lo7 cfu log phase E. cloacaelm1 after several hours. Trimethoprim 12.5 ,ug/ml caused a 10-fold fall in viable count after 5 h, an effect that was enhanced in the presence of sulphadiazine 250 pg/ml ( fig. 4) . After 24 h the viable counts were lo9 cfu/ml (sulphadiazine), 3 x 10' cfu/ml (trimethoprim), and 3 x lo5 cfu/ml (sulphadiazine plus trimethoprim).
Discussion
Thin sections of E. cloacae NCTC 10005 exposed to sulphadiazine and trimethoprim or disodium edetate plus lysozyme showed electron-transparent areas devoid of ribosomes in the bacterial cytoplasm. Ciprofloxacin can cause similar damage to Escherichia coli.' It may be assumed that protein synthesis would be affected by such damage.
Disodium edetate plus lysozyme causes hydrolysis of the peptidoglycan layer of gram-negative bacteria and morphological effects on PseudomonasJluorescens similar to those shown here." The similarity between the effects of lysozyme and the antifolate drugs sugzcbtb that trimcthoprim. rind to ;t lesser extent sulphadiazine. ma)' have a n additional effect on the production of peptidoglycan in E. ( h i c u e . I t is likely that the enhanced effect of the combination of sulphadiazine and trimethoprim is due to increased uptake into damaged bacterial cells as suggested pre\.tously.
Viable counts ol'cultiires treated in exactly the same way a s those from M,hich the elsctronmicrographs ivere prepared indicate that. although sulphadiazine 250 pg/mt merei! inhibited growth of log phase cells o f E. ( l o c r c u c m c r a 5-h period. it nevertheless inci~ascd thc bactericidal activity of trirnethoprim 12.5 rig nil nithin 2 h and throughout the 5-h period. More(,\ er. inhibition by sulphadiazine and the bactericidal effect of trimethoprim usere short in duration but thc effect o f the combination was longer lasting.
There is considcrable controvers). about the interaction bt.tN,eeti sulphadiazine and trimethoprim against sulphadiazine-resistant cells6 and in conditions in which trimethoprim alone is able to halt bacterial growth completely. Brumfitt and Hamilton-Miller stated that "synergy does not occur with bacteria that are resistant to sulphonamides '16 and Greenwood stated * * on theoretical grounds one would predict that sulphamethoxazole would be antagonized by the presence of inhibitory concentrations of trimethoprim * . . 7 However, under the conditions reported here, the presence of sulphadiazine contributed to the overall activity of the combination of sulphadiazine with trimethoprim both against sulphadiazine-resistant cells and also in the situation in which trimethoprim alone had a bactericidal action. While these results cannot be extrapolated directly to the clinical situation they nevertheless provide experimental evidence of potential benefit from the combination of sulphadiazine with trimethoprim.
